Takeda (TSE:4502/NYSE:TAK) today announced new interim data from the Phase 1b, open-label, proof-of-concept study of subcutaneous mezagitamab (TAK-079), an anti-CD38 monoclonal antibody with ...
− Takeda Initiated Pivotal Phase 3 Clinical Trials Evaluating Mezagitamab in Primary IgA Nephropathy and Immune Thrombocytopenia with Patient Enrollment Ongoing OSAKA, Japan & CAMBRIDGE, Mass., ...
− Takeda Initiated Pivotal Phase 3 Clinical Trials Evaluating Mezagitamab in Primary IgA Nephropathy and Immune Thrombocytopenia with Patient Enrollment Ongoing Takeda (TSE:4502/NYSE:TAK) today ...
Kai Tak Sports Park is “operationally sound” with bookings confirmed well into 2027, according to the city’s culture chief, adding that the function of Hong Kong Stadium’s main pitch may be ...
Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Amilcar has 10 years of FinTech, blockchain, ...
The Kai Tak Development Area, once home to Hong Kong’s iconic airport, is now the site of one of the city’s most ambitious urban regeneration efforts. As the government pushes forward with two major ...
Hello, everyone, and welcome to this investor call to discuss oveporexton Phase III data and commercial readiness. My name is Christopher O'Reilly, Head of Investor Relations at Takeda. Today's ...
Community driven content discussing all aspects of software development from DevOps to design patterns. Git isn’t hard to learn. Moreover, with a Git GUI such as Atlassian’s Sourcetree, and a SaaS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback